vigilneuro.com (VIGL) Cash Funds Calculated per Share

Corporate emblem and logo of Vigil Neuroscience Inc. (VIGL)

Vigil Neuroscience (VIGL) maintains a high reputation in the development of targeted antibodies to combat rare neurodegenerative pathologies. Fluctuations in cash position per share confirm financial stability, where the value of 1.40 reflects this status. The company's innovations are based on microglia activation to clear the brain in Alzheimer's disease, which drives long-term confidence among specialized investment funds in the brand's clinical potential.

Cash per Share: Vigil Neuroscience, Inc. (VIGL) for 07/04/2022 - 08/16/2025

Analytical breakdowns for Vigil Neuroscience

- market price and analyst price targets:
- cash position and cash flow details:
Summary company analysis:VIGL Vigil Neuroscience, Inc.
Original product of vigilneuro.com

Cash per share determines the portion of liquid assets attributable to a single security. This metric measures the internal financial buffer available to cover operating expenses. For Vigil Neuroscience (VIGL), this reserve is critical during the development of drugs targeting rare forms of dementia. By analyzing the trend of liquid assets per share, an investor assesses the company's autonomy. A stable cash balance minimizes default risks during prolonged clinical trials.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Minerva Neurosciences Corp - Cash per Single Share|Amount of Cash per Share ATHA|ADXN - Cash Funds per Share|Cash on Hand per Share Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Cash Funds per Share|Cash Funds per Single Share PTIX|KTTA (pasitheaclinics.com) - Cash per Share|CRGT (cortigent.com) - Cash Calculated per Single Share|Cash per Share ATXI|Cash Funds per Share BCLI (Brainstorm Cell)|Cash per Share CARA (Cara Therapeutics Inc)|Amount of Cash per Share CHRO|Eliem Therapeutics Inc. - Cash per Share|ITCI - Cash per Share|Longboard Pharma (LBPH) - Cash Funds per Share|Cash per Single Share Marinus Pharmaceuticals|Cash Funds per Share NKGen|Cash per Share NeuroBo Pharmaceuticals, Inc.|Cash per Share SAGE|Synaptogenix, Inc - Cash Funds per Single Share|Cash Funds per Share Trevena TRVN|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share